prostate cancer tissue microarray slides (U.S Biomax Inc)
Structured Review

Prostate Cancer Tissue Microarray Slides, supplied by U.S Biomax Inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prostate+tissue+microarray+slides/Normal+prostate+tissue+array%2C+24+cases%2F+48+cores/pmc09257407-276-4-16
Average 91 stars, based on 1 article reviews
Images
1) Product Images from "Peroxiredoxin IV plays a critical role in cancer cell growth and radioresistance through the activation of the Akt/GSK3 signaling pathways"
Article Title: Peroxiredoxin IV plays a critical role in cancer cell growth and radioresistance through the activation of the Akt/GSK3 signaling pathways
Journal: The Journal of Biological Chemistry
doi: 10.1016/j.jbc.2022.102123
Figure Legend Snippet: Examination of Prx4 protein levels in patient specimens of prostate cancer by tissue microarray or established prostate cancer cell lines by Western blotting. A , tissue microarray slides and representative images of anti-Prx4 staining of prostate normal and adenocarcinoma. Positive anti-Prx4 staining shows in dark brown and counter staining for nuclear shows light blue . The scale bars represent 5 mm (whole slide), 500 μm (individual tumor), and 100 μm (zoomed in). B and C , anti-Prx4 staining intensity were quantitatively scored by board-certified pathologist and data were compared between prostate normal (n = 50) and adenocarcinoma (n = 66) ( B ), as well as between prostate normal and cancer with different levels of Gleason grading ( C ). D , examination of Prx4 levels in prostate derived nontumorigenic or tumor cell lines by Western blotting. The bar graph on the right shows quantitative data from three independent blots. ∗ p < 0.05 by two-way ANOVA. Prx, peroxiredoxin.
Techniques Used: Microarray, Western Blot, Staining, Derivative Assay
Related Articles
Microarray:Article Title: Peroxiredoxin IV plays a critical role in cancer cell growth and radioresistance through the activation of the Akt/GSK3 signaling pathways Article Snippet: .. Human prostate normal and Article Title: The Polycomb Repressor Complex 1 Drives Double Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression Article Snippet: Luciferase labeled Pten PC-/- Smad4 PC-/- cells were generated by infecting the cells with a lenti-virus vector expressing luciferase and mCherry followed by FACS selection. .. Human Pathology Paraffin-embedded tissue microarray sections with multiple cores of Article Title: Cx43 Present at the Leading Edge Membrane Governs Promigratory Effects of Osteoblast-Conditioned Medium on Human Prostate Cancer Cells in the Context of Bone Metastasis Article Snippet: .. The same experiment was done using a Article Title: Long chain fatty acyl-CoA synthetase 1 promotes prostate cancer progression by elevation of lipogenesis and fatty acid beta-oxidation Article Snippet: Immunohistochemical (IHC) was performed to measure expression levels of ACSL1 (1:100; Cell Signaling #4047), Ki67 (1:400; Novus Biologicals, #NB500–170B) and CD34 (1:2000; Abcam, # ab81289). .. IHC staining of ACSL1 was also performed on Article Title: Proproliferative function of adaptor protein GRB10 in prostate carcinoma Article Snippet: .. Article Title: Long-chain fatty acyl-CoA synthetase 1 promotes prostate cancer progression by elevation of lipogenesis and fatty acid beta-oxidation. Article Snippet: Immunohistochemical (IHC) was performed to measure expression levels of ACSL1 (1:100; Cell Signaling #4047), Ki67 (1:400; Novus Biologicals, #NB500-170B), and CD34 (1:2000; Abcam, # ab81289). .. IHC staining of ACSL1 was also performed on Immunohistochemistry:Article Title: Long chain fatty acyl-CoA synthetase 1 promotes prostate cancer progression by elevation of lipogenesis and fatty acid beta-oxidation Article Snippet: Immunohistochemical (IHC) was performed to measure expression levels of ACSL1 (1:100; Cell Signaling #4047), Ki67 (1:400; Novus Biologicals, #NB500–170B) and CD34 (1:2000; Abcam, # ab81289). .. IHC staining of ACSL1 was also performed on Article Title: Long-chain fatty acyl-CoA synthetase 1 promotes prostate cancer progression by elevation of lipogenesis and fatty acid beta-oxidation. Article Snippet: Immunohistochemical (IHC) was performed to measure expression levels of ACSL1 (1:100; Cell Signaling #4047), Ki67 (1:400; Novus Biologicals, #NB500-170B), and CD34 (1:2000; Abcam, # ab81289). .. IHC staining of ACSL1 was also performed on Staining:Article Title: Long chain fatty acyl-CoA synthetase 1 promotes prostate cancer progression by elevation of lipogenesis and fatty acid beta-oxidation Article Snippet: Immunohistochemical (IHC) was performed to measure expression levels of ACSL1 (1:100; Cell Signaling #4047), Ki67 (1:400; Novus Biologicals, #NB500–170B) and CD34 (1:2000; Abcam, # ab81289). .. IHC staining of ACSL1 was also performed on Article Title: Long-chain fatty acyl-CoA synthetase 1 promotes prostate cancer progression by elevation of lipogenesis and fatty acid beta-oxidation. Article Snippet: Immunohistochemical (IHC) was performed to measure expression levels of ACSL1 (1:100; Cell Signaling #4047), Ki67 (1:400; Novus Biologicals, #NB500-170B), and CD34 (1:2000; Abcam, # ab81289). .. IHC staining of ACSL1 was also performed on other:Article Title: JAB1/COPS5 is a putative oncogene that controls critical oncoproteins deregulated in prostate cancer. Article Snippet: Recent evidence support that the c-Jun activation domain-binding protein 1 (JAB1)/COPS5 has an oncogenic function in various tissues.. We show that JAB1 amplification in human prostate cancer (PCa) correlates with reduced overall survival and disease-free progression.. Immunohistochemical staining shows enhanced expression of JAB1 in the cytoplasmic compartment of PCa cells compared to the normal prostate epithelium, indicating the activity/function of JAB1 is altered in PCa. Article Title: Preclinical Efficacy of a PARP-1 Targeted Auger-Emitting Radionuclide in Prostate Cancer Article Snippet: The prostate cancer tissue microarray (TMA) was purchased from US Biomax, Inc. (Rockville, MD, USA). |

